Websites using measure frequency as a keyword

Audio Processing and Audio Programming by V.Burel

Supplier of Industrial devices and components for Industrial Automation, Environmental Monitoring, Energy Management, Power Quality and Electric Protection.

Telnet Communication Limited (TCL) is committed to serve you from a single contact point. Telnet has a metro digital network that flows through every part of the Dhaka city and a nationwide backbone that connecting all the major cities of Bangladesh.

VoiceMeeter Virtual Audio Device Mixer by V.Burel

VB-Audio Virtual Cable and App's

Blog description here

SonTek manufactures acoustic Doppler instrumentation for water velocity measurement (flow and current monitoring) in oceans, rivers, lakes, harbors, canals, estuaries, industrial pipes and laboratories. SonTek’s sophisticated and proprietary technology serves as the foundation for some of the industry’s most trusted data collection systems such as the hand-held CastAway-CTD, the flexible Argonaut-SL series and more recently, the SonTek HydroSurveyor bathymetric ADCP. SonTek is headquartered in San Diego, California, and is a brand of Xylem Inc. www.sontek.com

株式会社ケツト科学研究所

Time + Frequency

Learn to build high performance DIY loudspeakers

Learn about HEMLIBRA® (emicizumab-kxwh), a hemophilia A treatment now approved for people with hemophilia A with factor VIII inhibitors. See BOXED WARNING. What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with hemophilia A with factor VIII inhibitors. What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. Discontinue prophylactic use of bypassing agents the day before starting HEMLIBRA prophylaxis. Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent, and the dose and schedule you should use. HEMLIBRA may cause the following serious side effects when used with aPCC (FEIBA®), including: Thrombotic microangiopathy (TMA). This is a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs. Get medical help right away if you have any of the signs and symptoms of TMA during or after treatment with HEMLIBRA. Blood clots (thrombotic events). Blood clots may form in blood vessels in your arm, leg, lung or head. Get medical help right away if you have any of the signs or symptoms of blood clots during or after treatment with HEMLIBRA. If aPCC (FEIBA®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (FEIBA®) total. How should I use Hemlibra? See the detailed “Instructions for Use” that comes with your HEMLIBRA for information on how to prepare and inject a dose of HEMLIBRA, and how to properly throw away (dispose of) used needles and syringes. HEMLIBRA may interfere with laboratory tests that measure how well your blood is clotting and may cause a false reading. Talk to your healthcare provider about how this may affect your care. What are the other possible side effects of HEMLIBRA? The most common side effects of HEMLIBRA include: redness, tenderness, warmth, or itching at the site of injection; headache; and joint pain. These are not all of the possible side effects of HEMLIBRA. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Please see the HEMLIBRA full Prescribing Information and Medication Guide for more important safety information including Serious Side Effects.